Pottecher, Julien <br/><br/>
Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients.  [electronic resource] 

 -  Trials  Mar 2020 
 - 274 p.  digital 
<br/><br/> Publication Type: Clinical Trial Protocol; Journal Article 
<br/><br/><label>ISSN: </label>1745-6215 
<br/><br/><label>Standard No.: </label>10.1186/s13063-020-4141-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aerosols<br/>Bayes Theorem<br/>Clinical Trials, Phase III as Topic<br/>Deoxyribonuclease I--administration & dosage<br/>Double-Blind Method<br/>Extracellular Traps--drug effects<br/>Humans<br/>Hypoxia--drug therapy<br/>Incidence<br/>Injury Severity Score<br/>Multicenter Studies as Topic<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--administration & dosage<br/>Respiration, Artificial--adverse effects<br/>Respiratory Distress Syndrome--drug therapy<br/>Wounds and Injuries--physiopathology